iShares Genomics Immunology and Healthcare ETF (IDNA)
NYSEARCA: IDNA · Real-Time Price · USD
31.00
+0.17 (0.55%)
Apr 22, 2026, 10:47 AM EDT - Market open
IDNA Holdings Information
IDNA is an equity ETF with a total of 65 individual holdings. The top holdings are Moderna stock at 6.69%, Revolution Medicines at 6.24%, Arcellx at 4.96%, Ipsen at 4.58%, and Bayer Aktiengesellschaft at 4.26%.
Total Holdings
65
Top 10 Percentage
46.33%
Asset Class
Equity
ETF Category
Health
Assets
167.86M
PE Ratio
14.67
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 6.69% |
| 2 | RVMD | Revolution Medicines, Inc. | 6.24% |
| 3 | ACLX | Arcellx, Inc. | 4.96% |
| 4 | EPA: IPN | Ipsen S.A. | 4.58% |
| 5 | ETR: BAYN | Bayer Aktiengesellschaft | 4.26% |
| 6 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 4.20% |
| 7 | LON: GSK | GSK plc | 4.09% |
| 8 | MRK | Merck & Co., Inc. | 3.99% |
| 9 | BNTX | BioNTech SE | 3.71% |
| 10 | SWX: ROP | Roche Holding AG | 3.62% |
| 11 | TWST | Twist Bioscience Corporation | 3.60% |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | 3.54% |
| 13 | EXEL | Exelixis, Inc. | 3.34% |
| 14 | EPA: SAN | Sanofi | 3.31% |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 3.27% |
| 16 | INCY | Incyte Corporation | 3.21% |
| 17 | CPH: GMAB | Genmab A/S | 3.00% |
| 18 | IDYA | IDEAYA Biosciences, Inc. | 2.81% |
| 19 | IBRX | ImmunityBio, Inc. | 2.71% |
| 20 | CAI | Caris Life Sciences, Inc. | 2.44% |
| 21 | TYO: 4528 | Ono Pharmaceutical Co., Ltd. | 1.83% |
| 22 | CRSP | CRISPR Therapeutics AG | 1.78% |
| 23 | RCUS | Arcus Biosciences, Inc. | 1.70% |
| 24 | NVAX | Novavax, Inc. | 1.28% |
| 25 | IOVA | Iovance Biotherapeutics, Inc. | 1.25% |
As of Apr 20, 2026